Best Agrolife Ltd
Best Agrolife (formerly known as Sahyog Multibase Limited) [1] is a leading agrochemicals manufacturer in India and is among the top 15 agrochemicals companies in the country. It is one of the fastest growing manufacturers of Technicals, Formulations, Intermediates and Public Health products. Best Agrochem Private Limited was amalgamated with the Co. in April 2018.
It offers more than 70 Formulations in the form of Insecticides, Herbicides, Fungicides and Plant Growth Regulators, which are developed from active ingredients manufactured in-house. As part of its P2P set-up, Best Agrolife caters to several blue-chip corporates and leading MNCs from India and abroad. [2]
- Market Cap ₹ 566 Cr.
- Current Price ₹ 16.0
- High / Low ₹ 35.8 / 12.3
- Stock P/E 18.6
- Book Value ₹ 13.2
- Dividend Yield 1.25 %
- ROCE 10.5 %
- ROE 6.66 %
- Face Value ₹ 1.00
Pros
- Company's median sales growth is 27.8% of last 10 years
Cons
- The company has delivered a poor sales growth of 0.04% over past five years.
- Company has a low return on equity of 7.21% over last 3 years.
- Working capital days have increased from 62.8 days to 94.9 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals
Part of BSE Commodities
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 9 | 99 | 129 | 663 | 690 | 905 | 1,134 | 1,500 | 1,798 | 1,144 | 907 | |
| 0 | 9 | 98 | 132 | 652 | 675 | 854 | 1,009 | 1,414 | 1,736 | 1,041 | 838 | |
| Operating Profit | -0 | -0 | 1 | -3 | 11 | 15 | 51 | 125 | 86 | 62 | 103 | 69 |
| OPM % | -2% | 1% | -2% | 2% | 2% | 6% | 11% | 6% | 3% | 9% | 8% | |
| 0 | 0 | 0 | 4 | 2 | 4 | 7 | 5 | 10 | 6 | 6 | 10 | |
| Interest | 0 | 0 | 1 | 1 | 5 | 6 | 5 | 11 | 24 | 43 | 41 | 30 |
| Depreciation | 0 | 0 | 0 | 0 | 1 | 2 | 3 | 4 | 5 | 7 | 7 | 6 |
| Profit before tax | 0 | 0 | 0 | 0 | 7 | 12 | 51 | 116 | 67 | 19 | 61 | 42 |
| Tax % | 20% | 43% | 567% | 175% | 36% | 29% | 27% | 25% | 30% | 30% | 27% | 28% |
| 0 | 0 | -0 | -0 | 5 | 8 | 37 | 87 | 47 | 13 | 44 | 30 | |
| EPS in Rs | 0.01 | 0.01 | -0.03 | -0.00 | 0.39 | 0.69 | 1.12 | 2.45 | 1.33 | 0.38 | 1.25 | 0.86 |
| Dividend Payout % | 0% | 76% | -57% | -399% | 0% | 3% | 12% | 5% | 15% | 53% | 16% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 59% |
| 5 Years: | 0% |
| 3 Years: | -15% |
| TTM: | -21% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 94% |
| 5 Years: | -4% |
| 3 Years: | -14% |
| TTM: | -32% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | -4% |
| 3 Years: | -39% |
| 1 Year: | -28% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 12% |
| 3 Years: | 7% |
| Last Year: | 7% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3 | 3 | 8 | 8 | 22 | 22 | 22 | 24 | 24 | 24 | 24 | 35 |
| Reserves | 0 | 0 | 41 | 43 | 156 | 62 | 108 | 289 | 336 | 342 | 420 | 434 |
| 0 | 0 | 0 | 8 | 39 | 35 | 32 | 137 | 286 | 348 | 252 | 205 | |
| 0 | 1 | 38 | 22 | 265 | 217 | 209 | 260 | 283 | 443 | 279 | 228 | |
| Total Liabilities | 3 | 4 | 87 | 81 | 482 | 336 | 371 | 709 | 928 | 1,157 | 975 | 902 |
| 0 | 0 | 0 | 0 | 110 | 15 | 19 | 21 | 33 | 32 | 34 | 33 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Investments | 0 | 0 | 26 | 3 | 4 | 5 | 0 | 102 | 102 | 116 | 122 | 122 |
| 3 | 4 | 60 | 78 | 369 | 315 | 352 | 586 | 793 | 1,007 | 819 | 746 | |
| Total Assets | 3 | 4 | 87 | 81 | 482 | 336 | 371 | 709 | 928 | 1,157 | 975 | 902 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | -0 | -13 | -35 | 60 | 16 | 10 | -0 | -128 | -35 | 131 | 123 | |
| 0 | 0 | -36 | 25 | -5 | -5 | 12 | -97 | 55 | -20 | -14 | -37 | |
| 0 | 0 | 48 | 11 | -45 | -13 | -12 | 90 | 118 | 12 | -107 | -85 | |
| Net Cash Flow | 0 | 0 | -0 | 0 | 11 | -3 | 10 | -8 | 45 | -42 | 9 | 1 |
| Free Cash Flow | 0 | -0 | -13 | -35 | 53 | 12 | 7 | -7 | -135 | -41 | 127 | 120 |
| CFO/OP | -367% | 129% | -1,211% | 1,209% | 555% | 124% | 41% | 22% | -104% | -35% | 134% | 199% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 88 | 72 | 86 | 112 | 92 | 53 | 75 | 73 | 66 | 103 | 110 | |
| Inventory Days | 0 | 31 | 31 | 43 | 42 | 67 | 77 | 90 | 86 | 122 | 134 | |
| Days Payable | 75 | 53 | 141 | 101 | 72 | 82 | 63 | 83 | 84 | 81 | ||
| Cash Conversion Cycle | 88 | 29 | 63 | 14 | 33 | 48 | 70 | 100 | 69 | 141 | 164 | |
| Working Capital Days | 111 | 76 | 156 | 14 | 24 | 34 | 50 | 32 | 28 | 66 | 95 | |
| ROCE % | 2% | 2% | 5% | -2% | 8% | 11% | 40% | 41% | 17% | 9% | 14% | 11% |
Insights
In beta| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Number of Distributors Count |
|
|||||||
| Total Headcount (Employees) Count |
||||||||
| Formulations Manufacturing Capacity MTPA/KL |
||||||||
| Formulations Registrations (India) Count |
||||||||
| Technicals Manufacturing Capacity MTPA |
||||||||
Extracted by Screener AI
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Earnings Call Transcript 1 Jun
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
28 May - Audio recording of Q4 FY2026 earnings conference call uploaded on company website.
-
General-Update
28 May - Best Agrolife shared FY26 presentation: revenue ₹1,257 crore, PAT ₹1 crore, 3 launches and 7 patents.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 28 May
-
Statement Of Deviation For The Quarter March 31, 2026.
27 May - No deviation in ₹150 crore warrant proceeds; ₹76.5 crore received in quarter ended 31 March 2026.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Concalls
-
May 2026Transcript PPT REC
-
Feb 2026Transcript PPT REC
-
Nov 2025TranscriptPPT
-
Aug 2025Transcript PPT REC
-
May 2025Transcript PPT
-
May 2025TranscriptAI SummaryPPT
-
Feb 2025TranscriptPPTREC
-
Oct 2024Transcript PPT REC
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Dec 2023TranscriptAI SummaryPPT
-
Nov 2023TranscriptPPT
-
Aug 2023Transcript PPT
-
Jun 2023Transcript PPT REC
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Sep 2020TranscriptAI SummaryPPT
Business Overview
The company is the 13th Largest Indian Agrochemical Company, with a portfolio of 525+ formulations and 123+ technical manufacturing licenses. It offers a wide range of herbicides, insecticides, fungicides, and plant growth regulators including Ronfen, Citigen, Tricolor, Azaro, Cubax Power, etc. [1] [2] [3]